Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Sène D, Levasseur F, Abel M, Lambert M, Camous X, Hernandez C, Pène V, Rosenberg AR, Jouvin-Marche E, Marche PN, Cacoub P, Caillat-Zucman S.

PLoS Pathog. 2010 Nov 11;6(11):e1001184. doi: 10.1371/journal.ppat.1001184.

2.

Immunological changes in different patient populations with chronic hepatitis C virus infection.

Szereday L, Meggyes M, Halasz M, Szekeres-Bartho J, Par A, Par G.

World J Gastroenterol. 2016 May 28;22(20):4848-59. doi: 10.3748/wjg.v22.i20.4848.

3.

HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.

Wang XX, Pan XB, Han JC, Cong X, Jin Q, Kong XS, Wei L, Feng B.

Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):233-240. doi: 10.1016/j.hbpd.2018.03.010. Epub 2018 Mar 26.

PMID:
29625837
4.

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, Boesecke C, Sauerbruch T, Rockstroh JK, Spengler U, Nattermann J.

J Hepatol. 2013 Sep;59(3):427-33. doi: 10.1016/j.jhep.2013.04.029. Epub 2013 May 9.

PMID:
23665286
5.

Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection.

Wolter F, Glässner A, Krämer B, Kokordelis P, Finnemann C, Kaczmarek DJ, Goeser F, Lutz P, Nischalke HD, Strassburg CP, Spengler U, Nattermann J.

J Hepatol. 2015 Dec;63(6):1334-44. doi: 10.1016/j.jhep.2015.08.008. Epub 2015 Aug 20.

PMID:
26297916
6.

Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.

Kim H, Bose SK, Meyer K, Ray R.

J Virol. 2014 Mar;88(5):2564-71. doi: 10.1128/JVI.02988-13. Epub 2013 Dec 18. Erratum in: J Virol. 2017 Nov 30;91(24):.

7.

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Yoon JC, Lim JB, Park JH, Lee JM.

J Virol. 2011 Dec;85(23):12557-69. doi: 10.1128/JVI.00838-11. Epub 2011 Sep 21.

8.

Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.

Krämer B, Körner C, Kebschull M, Glässner A, Eisenhardt M, Nischalke HD, Alexander M, Sauerbruch T, Spengler U, Nattermann J.

Hepatology. 2012 Oct;56(4):1201-13. doi: 10.1002/hep.25804. Epub 2012 Aug 31.

PMID:
22532190
9.

Activation of natural killer cells by hepatitis C virus particles in vitro.

Farag MM, Weigand K, Encke J, Momburg F.

Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x. Epub 2011 Jun 17.

10.

Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, Suzuki T, Miyagi T, Hayashi N.

J Immunol. 2003 Nov 15;171(10):5423-9.

11.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

12.
13.

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.

Muntasell A, Magri G, Pende D, Angulo A, López-Botet M.

Blood. 2010 Jun 24;115(25):5170-9. doi: 10.1182/blood-2009-11-256479. Epub 2010 Apr 14.

14.

Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers.

Mozer-Lisewska I, Mania A, Kowala-Piaskowska A, Kluk A, Samara H, Pauli A, Żeromski J.

Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):153-60.

15.

Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.

El Sobky SA, El-Ekiaby NM, Mekky RY, Elemam NM, Mohey Eldin MA, El-Sayed M, Esmat G, Abdelaziz AI.

Immunol Lett. 2016 Jan;169:52-60. doi: 10.1016/j.imlet.2015.10.013. Epub 2015 Oct 27.

PMID:
26518141
16.

Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.

Støy S, Dige A, Sandahl TD, Laursen TL, Buus C, Hokland M, Vilstrup H.

Am J Physiol Gastrointest Liver Physiol. 2015 Feb 15;308(4):G269-76. doi: 10.1152/ajpgi.00200.2014. Epub 2014 Dec 11.

17.

Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions.

Holder KA, Stapleton SN, Gallant ME, Russell RS, Grant MD.

J Immunol. 2013 Sep 15;191(6):3308-18. doi: 10.4049/jimmunol.1300164. Epub 2013 Aug 19.

18.

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

Alter G, Jost S, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, Altfeld M, Lauer GM.

J Hepatol. 2011 Aug;55(2):278-88. doi: 10.1016/j.jhep.2010.11.030. Epub 2010 Dec 17.

19.

TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H.

PLoS Pathog. 2012;8(3):e1002594. doi: 10.1371/journal.ppat.1002594. Epub 2012 Mar 15.

20.

Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models.

Elemam NM, Mekky RY, El-Ekiaby NM, El Sobky SA, El Din MA, Esmat G, Abdelaziz AI.

Hum Immunol. 2015 Sep;76(9):687-94. doi: 10.1016/j.humimm.2015.09.021. Epub 2015 Sep 30.

PMID:
26429314

Supplemental Content

Support Center